Tracked deals
12
12 tracked deals across 2021-2025.
Operating Company
Healthcare
Flourish Research
Apex, North Carolina, United States
Flourish Research is a fully integrated, multi-site clinical trial network serving sponsors and CROs across North America. It conducts Phase I–IV studies in oncology, neuroscience (with a focus on Alzheimer’s disease), cardiovascular, and metabolic indications, delivering expert site leadership and predictable recruitment at scale.
- Focus Areas
- Clinical trial site network, Phase I–IV clinical trials, Oncology clinical trials
- Website
- flourishresearch.com
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
6 addon · 5 recapitalization · 1 buyout
Flourish Research Acquisition Volume by Year
Last 5 years
Supporting Data
Recent Transactions
-
October 6, 2025
- Buyer
- Flourish Research, Genstar Capital
- Target
- Valkyrie Clinical Trials
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Addon
Flourish Research, a Genstar Capital-backed multi-site clinical trial organization, has made a strategic investment in Valkyrie Clinical Trials to establish a meaningful presence in oncology. Valkyrie, founded by Dr. David Berz and operating three sites in Los Angeles, will leverage Flourish's national network and infrastructure to accelerate oncology trial access and patient recruitment.
-
- Buyer
- Flourish Research
- Target
- Center for Advanced Research & Education (CARE)
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Type
- Buyout
Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina, acquired the Center for Advanced Research & Education (CARE), a Gainesville, Georgia-based clinical research facility. The deal expands Flourish's geographic footprint into the Southeast, strengthens its oncology capabilities, and deepens relationships with pharmaceutical sponsor clients.
-
February 18, 2025
- Buyer
- Flourish Research
- Target
- Diablo Clinical Research
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Addon
Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina, has acquired Diablo Clinical Research, a Walnut Creek, California-based clinical research facility established in 1995 that has conducted more than 1,000 phase I–IV trials and medical device studies. The add-on acquisition (Flourish is PE-backed by Genstar Capital) expands Flourish's geographic footprint and therapeutic-area capabilities, particularly in endocrinology, cardiovascular and metabolic research.
-
June 25, 2024
- Buyer
- Flourish Research, NMS Capital
- Target
- ENCORE Research Group
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Addon
NMS Capital portfolio company Flourish Research has partnered with ENCORE Research Group, a clinical research organization with eight locations across Northern Florida and more than 100 investigators. The transaction — the eleventh add-on to the Flourish platform since 2021 — expands Flourish's geographic footprint and therapeutic capabilities; terms were not disclosed.
-
December 15, 2023
- Buyer
- Flourish Research, NMS Capital
- Target
- Merritt Island Medical Research
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Addon
Flourish Research, a multi‑site clinical research platform backed by NMS Capital, has acquired Merritt Island Medical Research (MIMR) in Merritt Island, Florida. The deal is an add‑on to Flourish's platform (its tenth acquisition) and strengthens its neuroscience clinical research capabilities; MIMR's founders and leadership will remain with the site.
-
September 15, 2023
- Buyer
- Flourish Research, NMS Capital
- Target
- Valley Clinical Trials
- Industry
- Healthcare Services
- Location
- California, United States
- Type
- Addon
NMS Capital–backed Flourish Research has acquired Valley Clinical Trials, a three-site clinical research organization in Los Angeles County focused on cardiology, metabolic and related therapeutic areas. The deal — Flourish’s ninth acquisition since 2021 — expands the platform’s West Coast footprint; terms were not disclosed and Valley’s founder and management will remain in their roles.
-
May 18, 2023
- Buyer
- Flourish Research, NMS Capital
- Target
- AMC Research, LLC, Central Research Associates
- Seller
- Dr. Reza Bolouri, Dr. William Whitley, Company management
- Industry
- Healthcare Services
- Location
- United States
- Type
- Recapitalization
NMS Capital portfolio company Flourish Research partnered with company management to recapitalize AMC Research, LLC (Charlotte, NC) and Central Research Associates (Birmingham, AL). The transactions expand Flourish’s clinical research site network—augmenting its Alzheimer’s capabilities and adding scale in cardiology/metabolic/renal, vaccine and other therapeutic areas; terms were not disclosed.
-
December 22, 2022
- Buyer
- Flourish Research, NMS Capital
- Target
- Suncoast Research Group
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Addon
Flourish Research, an NMS Capital portfolio company, has acquired Suncoast Research Group, a multi-therapeutic clinical research site based in the Little Havana neighborhood of Miami, Florida. The founders and current management will remain in place; terms were not disclosed. The deal expands Flourish's integrated clinical site network and increases access to diverse patient populations in the Florida market.
-
- Buyer
- Flourish Research, NMS Capital
- Target
- Keystone Clinical Studies, LLC
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Type
- Recapitalization
Flourish Research, a portfolio company of NMS Capital, partnered with Keystone Clinical Studies' management in a recapitalization transaction. Keystone, a Plymouth Meeting, Pennsylvania-based clinical research site focused on Alzheimer’s disease and CNS conditions, will continue to be led by founder Dr. Cherian Verghese as part of the Flourish platform to expand CNS capabilities and enter the Philadelphia market.
-
January 12, 2022
- Buyer
- Flourish Research, NMS Capital
- Target
- Great Lakes Clinical Trials, Clinical Site Partners
- Industry
- Healthcare Services
- Location
- United States
- Type
- Recapitalization
NMS Capital portfolio company Flourish Research completed recapitalizations of Great Lakes Clinical Trials and Clinical Site Partners, expanding its multi-site clinical trial network across Illinois, Florida and Texas. The deals (terms undisclosed) add site capacity and management teams to Flourish Research as the platform pursues network consolidation, improved operational efficiencies and accelerated growth.
-
- Buyer
- Flourish Research, NMS Capital
- Target
- Excel Medical Clinical Trials, LLC
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Recapitalization
NMS Capital portfolio company Flourish Research partnered with Excel Medical Clinical Trials in a recapitalization. The Boca Raton, Florida-based clinical research site, founded by Dr. Seth Baum and focused on cardiology indications, will join Flourish's site network to expand the platform's geographic footprint and therapeutic capabilities; terms were not disclosed and management will remain in place.
-
- Buyer
- NMS Capital, Flourish Research
- Target
- Clinical Trials of Texas
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Recapitalization
NMS Capital formed a new platform, Flourish Research, and completed a recapitalization of Clinical Trials of Texas (CTT) in partnership with founder Kay Scroggins and company management. The deal makes CTT the inaugural partner in a buy-and-build strategy to create a nationwide network of clinical research sites; CTT is headquartered in San Antonio, Texas, operates a 20,000+ sq. ft. facility and has conducted over 1,000 trials across more than 15 therapeutic areas.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
12 tracked deals by Flourish Research.
Acquisitions in Florida
4 tracked deals by Flourish Research.
Acquisitions in California
3 tracked deals by Flourish Research.
Acquisitions in Georgia
1 tracked deal by Flourish Research.
Acquisitions in Pennsylvania
1 tracked deal by Flourish Research.
Selling a company? Get in front of buyers like Flourish Research
Turn tracked acquisition activity into an outreach-ready buyer list.